Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS).
Aringer M, Arnaud L, Furie RA, Morand EF, Peschken C, Hoi A, Desta B, Hedberg J, Grünfeld Eén T, Sorrentino A, Kielar D, Tummala R, Chen S, Ding B. Aringer M, et al. Among authors: kielar d. Lupus Sci Med. 2025 Jan 23;12(1):e001336. doi: 10.1136/lupus-2024-001336. Lupus Sci Med. 2025. PMID: 39855677 Free article.
Impact of patient support programmes among patients with severe asthma treated with biological therapies: a systematic literature review and indirect treatment comparison.
Rabe APJ, Loke WJ, Kielar D, Morris T, Shih VH, Olinger L, Musat MG, Lan Z, Harricharan S, Fulton O, Majeed A, Heaney LG. Rabe APJ, et al. Among authors: kielar d. BMJ Open Respir Res. 2024 May 2;11(1):e001799. doi: 10.1136/bmjresp-2023-001799. BMJ Open Respir Res. 2024. PMID: 38697674 Free PMC article.
Acute rheumatic fever-a preventable, inequitable disease: a call for action.
Bennett J, Anderson A, 'Ofanoa M, Anderson P, Baker MG, Brown R, Devlin G, Eggleton K, Harwood M, Jansen RM, Kielar D, Malcolm J, Moreland NJ, Poskitt N, Sika-Paotonu D, Webb R, Wilson N. Bennett J, et al. Among authors: kielar d. N Z Med J. 2021 May 21;134(1535):93-95. N Z Med J. 2021. PMID: 34012146 No abstract available.
Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol.
van der Heijde D, Fleischmann R, Wollenhaupt J, Deodhar A, Kielar D, Woltering F, Stach C, Hoepken B, Arledge T, Mease PJ. van der Heijde D, et al. Among authors: kielar d. Ann Rheum Dis. 2014 Jan;73(1):233-7. doi: 10.1136/annrheumdis-2013-203697. Epub 2013 Aug 13. Ann Rheum Dis. 2014. PMID: 23942869 Free PMC article. Clinical Trial.
Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA).
Mease PJ, Fleischmann R, Deodhar AA, Wollenhaupt J, Khraishi M, Kielar D, Woltering F, Stach C, Hoepken B, Arledge T, van der Heijde D. Mease PJ, et al. Among authors: kielar d. Ann Rheum Dis. 2014 Jan;73(1):48-55. doi: 10.1136/annrheumdis-2013-203696. Epub 2013 Aug 13. Ann Rheum Dis. 2014. PMID: 23942868 Free PMC article. Clinical Trial.
Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries.
Moots RJ, Ostor AJ, Loft AG, Järvinen P, Larsson P, Ekelund M, Reynolds A, Kielar D, Lindkvist RM, Qvitzau S. Moots RJ, et al. Among authors: kielar d. Rheumatology (Oxford). 2012 Feb;51(2):393-6. doi: 10.1093/rheumatology/ker404. Epub 2011 Dec 30. Rheumatology (Oxford). 2012. PMID: 22210658 Clinical Trial.
20 results